FVCM
CVS icon

F&V Capital Management’s CVS Health CVS Stock Holding History

F&V Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Sell
140,557
-3,035
-2% -$271K 2.68% 18
2026
Q1 		$10.3M Sell
143,592
-1,960
-1% -$151K 2.18% 24
2025
Q4 		$11.6M Buy
145,552
+698
+0.5% +$55K 2.46% 22
2025
Q3 		$10.9M Buy
144,854
+1,985
+1% +$136K 2.45% 20
2025
Q2 		$9.86M Sell
142,869
-380
-0.3% -$24.9K 2.52% 21
2025
Q1 		$9.71M Buy
143,249
+7,735
+6% +$463K 2.52% 23
2024
Q4 		$6.08M Sell
135,514
-5,110
-4% -$287K 1.6% 26
2024
Q3 		$8.84M Buy
140,624
+1,445
+1% +$84.3K 2.27% 23
2024
Q2 		$8.22M Buy
139,179
+5,640
+4% +$353K 2.4% 22
2024
Q1 		$10.7M Buy
133,539
+1,590
+1% +$121K 3.14% 13
2023
Q4 		$10.4M Sell
131,949
-2,090
-2% -$149K 3.34% 11
2023
Q3 		$9.36M Sell
134,039
-2,205
-2% -$156K 3.21% 11
2023
Q2 		$9.42M Sell
136,244
-1,405
-1% -$100K 3.04% 14
2023
Q1 		$10.2M Buy
137,649
+940
+0.7% +$78.8K 3.39% 13
2022
Q4 		$12.7M Buy
136,709
+6,320
+5% +$610K 4.24% 6
2022
Q3 		$12.4M Buy
130,389
+33,735
+35% +$3.34M 4.8% 3
2022
Q2 		$8.96M Buy
96,654
+6,375
+7% +$622K 3.19% 15
2022
Q1 		$9.14M Buy
90,279
+3,340
+4% +$351K 2.77% 18
2021
Q4 		$8.97M Buy
86,939
+4,325
+5% +$400K 3.01% 17
2021
Q3 		$7.01M Sell
82,614
-6,205
-7% -$520K 2.81% 21
2021
Q2 		$7.41M Sell
88,819
-80
-0.1% -$6.55K 2.72% 23
2021
Q1 		$6.69M Buy
88,899
+2,224
+3% +$162K 2.5% 23
2020
Q4 		$5.92M Buy
86,675
+7,210
+9% +$469K 2.56% 23
2020
Q3 		$4.64M Buy
79,465
+3,105
+4% +$193K 2.26% 22
2020
Q2 		$4.96M Buy
76,360
+5,975
+8% +$376K 2.51% 20
2020
Q1 		$4.18M Sell
70,385
-110
-0.2% -$7.34K 2.66% 19
2019
Q4 		$5.24M Buy
+70,495
New +$4.95M 2.84% 16

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

F&V Capital Management's CVS Position: Q2 2026 in Review

F&V Capital Management reduced its CVS Health (CVS) stake by 2.1% in Q2 2026, selling an estimated $271K and leaving 140,557 shares worth $14.5M. The position accounts for 2.68% of the portfolio, ranked #18.

F&V Capital Management first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • F&V Capital Management held 140,557 shares of CVS Health worth $14.5M as of Q2 2026.
  • F&V Capital Management sold 3,035 CVS Health shares in Q2 2026, an estimated $271K.
  • CVS Health made up 2.68% of F&V Capital Management's portfolio in Q2 2026, its #18 holding.
  • F&V Capital Management first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on F&V Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.